Filing Flows

Filing Flows › Health Care › Precision Optics (POCI)

Precision Optics (POCI) earnings and revenue breakdown

Latest: Q4 FY26 · 10-K filed Sep 28, 2026 · Precision Optics (POCI) Q4 FY26 earnings results →

Q4 FY26 Revenue up 42% year over year to $8.8M · 1¢ of every $1 of revenue lost · operating margin -1.2%

Precision Optics made $8.8M in Q4 FY26 (+42% Y/Y): Systems Manufacturing $6.4M, Ross Optical Industries $1.5M, Engineering Design Services $795K. Operating margin -1.2%, net loss $104K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-K filed Sep 28, 2026.

Revenue$8.8M
Year over year+42%
Operating margin-1.2%
Net earnings−$104K
Operating cash flow−$649K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $8.8M in Q4 FY26, up 42% year over year and up 1% from the previous quarter. Systems Manufacturing was the largest line at 73% of revenue.

Gross margin was 25.3%, up 12.4 points from Q4 FY25. Operating costs exceeded revenue by $107K, an operating margin of -1.2%. Operating expenses grew 8% against revenue growth of 42%. The fastest-growing cost line was SG&A (+10%). The quarter ended with a net loss of $104K, narrower than the previous quarter's $108K loss.

Operating cash flow was −$649K. Non-cash charges added back $64K of depreciation and amortization and $397K of share-based compensation. Working capital and other items used $1.0M.

Quarterly history

Precision Optics revenue by quarterPrecision Optics revenue by quarter$4.5MQ2 FY25$4.2MQ3 FY25$6.2MQ4 FY25$6.7MQ1 FY26$7.4MQ2 FY26$8.7MQ3 FY26$8.8MQ4 FY26
Precision Optics net earnings by quarterPrecision Optics net earnings by quarter−$970KQ2 FY25−$2.1MQ3 FY25−$1.4MQ4 FY25−$1.6MQ1 FY26−$1.8MQ2 FY26−$108KQ3 FY26−$104KQ4 FY26
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q4 FY2610-KSep 28, 2026$8.8M+42%-1.2%−$104K−$649K
Q3 FY2610-QMay 13, 2026$8.7M+108%-0.7%−$108K−$723K
Q2 FY2610-QFeb 17, 2026$7.4M+63%-23.6%−$1.8M−$256K
Q1 FY2610-QNov 13, 2025$6.7M+59%-23.9%−$1.6M$78K
Q4 FY2510-KSep 29, 2025$6.2M+31%-21.9%−$1.4M−$418K
Q3 FY2510-QMay 15, 2025$4.2M-20%-48.7%−$2.1M−$1.9M
Q2 FY2510-QFeb 13, 2025$4.5M-6%-20.1%−$970K−$787K

Charts

Precision Optics: revenue growth, year over year and quarter over quarterPrecision Optics: revenue growth, year over year and quarter over quarterY/YQ/Q-6%Q2 FY25-20%-8%Q3 FY25+31%+48%Q4 FY25+59%+8%Q1 FY26+63%+10%Q2 FY26+108%+18%Q3 FY26+42%+1%Q4 FY26
Latest (Q4 FY26): Y/Y +42%, Q/Q +1%.
Precision Optics: where the cash came from (+) and went (−), FY26Precision Optics: where the cash came from (+) and went (−), FY26Shares issued$10.7MCash drawn (+) / kept (−)−$8.1MOperating cash flow−$1.6MNet borrowing (+) / repaid (−)−$596KCapital spending−$427KOther financing−$27KOther investing−$6KAsset & business sales$3K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Precision Optics: profit against cash, quarter by quarterPrecision Optics: profit against cash, quarter by quarterNet incomeOperating cash flow−$1.3M−$319KQ1 FY25−$970K−$787KQ2 FY25−$2.1M−$1.9MQ3 FY25−$1.4M−$418KQ4 FY25−$1.6M$78KQ1 FY26−$1.8M−$256KQ2 FY26−$108K−$723KQ3 FY26−$104K−$649KQ4 FY26
Latest (Q4 FY26): Net income −$104K, Operating cash flow −$649K.
Precision Optics: diluted shares by fiscal yearPrecision Optics: diluted shares by fiscal year13MFY215MFY226MFY236MFY247MFY259MFY26
-35.8% since FY21: buybacks shrank the count.
Precision Optics: long-term debt falling due (FY26)Precision Optics: long-term debt falling due (FY26)$596K2027$596K2028$141K2029
Cash $9.8M, short-term investments —, long-term debt $1.3M at 2026-06-30.
Precision Optics in its industry: growth against margin (25 companies, SIC 3845)Precision Optics in its industry: growth against margin (25 companies, SIC 3845)revenue growth, year over year →↑ operating marginmedian +14%median -8%MDTITGRLIVNCNMDTMDXAXGNOMCBLLBLFSELMDIRIXVASOFOCLECORSTXSQTIHYPRESMCCVNUWENRXSADMTPOSCNXLPOCI (+42%, -1%)
Electromedical & Electrotherapeutic Apparatus; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Precision Optics

We have been a developer and manufacturer of advanced optical instruments since 1982, and we operate primarily in two key market segments: medical devices and advanced defense/aerospace products. Within our proprietary optical and imaging technology, our unique custom designs, expert manufacturing capabilities, and advanced engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using CMOS sensor technology, some designed and manufactured for single-use, as well as other, more advanced, custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures.

In its own words, from its annual report, filed Sep 29, 2025.

Precision Optics against its Electromedical & Electrotherapeutic Apparatus peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +42% against the peers' median +14%. Operating margin: -1.2% against the peers' median 6.3%.

CompanyQuarterRevenueY/YOp. margin
POCI Precision OpticsQ4 FY26$8.8M+42%-1.2%
MDT MedtronicQ1 FY27$9.8B+14%18.1%
ITGR Integer HoldingsQ3 2026$450M-4%6.3%
LIVN LivaNovaQ3 2026$393M+10%7.2%
CNMD ConmedQ3 2026$336M-0.7%11.1%
TMDX TransMedics GroupQ3 2026$203M+41%13.9%
AXGN AxogenQ3 2026$75.8M+26%1.3%
OM Outset MedicalQ3 2026$33.6M+14%-36.5%
CBLL CeribellQ3 2026$29.3M+30%-70.0%

Source: Precision Optics 10-K on SEC EDGAR · CIK 867840 · Electromedical & Electrotherapeutic Apparatus

13F: who owns POCI and who is buying

Largest holders of POCI (13F)Largest holders of POCI (13F)Needham Investment Management LLC$8.5MNantahala Capital Management, LLC$2.9MMyda Advisors LLC$1.9MVanguard Capital Management LLC$1.7MWealthTrust Axiom LLC$1.3MVanguard Group$935KMorgan Stanley$916KHighTower Advisors, LLC$634KGeode Capital Management, LLC$337KRenaissance Technologies LLC$276K
Funds' net buying of POCI by quarter (13F)Funds' net buying of POCI by quarter (13F)$1.0M2024-09−$440K2024-12$1.7M2025-03$1.1M2025-06−$30K2025-09$98K2025-12$9.4M2026-03$280K2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on POCI

History

Every quarter: Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results

Compare POCI with

中文版：Precision Optics（POCI）财报

Español · Français